Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a $6.79 billion market cap biopharmaceutical ...

The tech-heavy Nasdaq Composite index slid 3.5 per cent shortly after the opening bell, while the broader S&P 500 fell about 2 per cent. Nvidia, which surged last year on bets that Big Tech companies ...

William John Sibold, the President and CEO of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), has sold shares of the company worth $531,020. The transaction involved the sale of 1,584 shares at a price ...

Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China's ...

Another difference between the public and private sectors.